New Collaboration to Automate Cell Therapy Manufacturing with Robotics
Focus on scaling cell therapy manufacturing using GMP-ready end-to-end robotic biomanufacturing technology
-
1
Multiply Labs has partnered with AstraZeneca to explore robotic automation in cell therapy manufacturing.
-
2
The collaboration aims to enhance scalable, high-throughput manufacturing while adhering to quality and regulatory standards.
-
3
Multiply Labs' robotic systems utilize four arms operating in parallel to optimize existing cell therapy production processes.
-
4
The initiative seeks to improve the efficiency and availability of complex cell therapies in clinical and commercial settings.
-
5
CEO Fred Parietti emphasizes the importance of combining scientific expertise with robotic technology for future advancements.
